Bette Caan to Prognosis
This is a "connection" page, showing publications Bette Caan has written about Prognosis.
Connection Strength
3.040
-
Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative. JAMA Netw Open. 2020 09 01; 3(9):e2016747.
Score: 0.153
-
Non-alcoholic fatty liver disease and colorectal cancer survival. Cancer Causes Control. 2019 Feb; 30(2):165-168.
Score: 0.135
-
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877.
Score: 0.124
-
Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
Score: 0.120
-
Next Steps in Understanding the Obesity Paradox in Cancer. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):12.
Score: 0.119
-
Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
Score: 0.118
-
Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
Score: 0.115
-
Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data. J Natl Cancer Inst. 2016 Mar; 108(3).
Score: 0.110
-
Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.105
-
Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
Score: 0.105
-
Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
Score: 0.097
-
Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
Score: 0.097
-
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
Score: 0.089
-
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
Score: 0.086
-
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
Score: 0.084
-
Genetic variation in the transforming growth factor-ß signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer. 2011 Sep 15; 117(18):4175-83.
Score: 0.079
-
Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):854-8.
Score: 0.079
-
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 Oct 20; 304(15):1684-92.
Score: 0.077
-
Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 06; 102(19):1468-77.
Score: 0.077
-
Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
Score: 0.068
-
Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
Score: 0.066
-
Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat. 2006 Sep; 99(1):47-57.
Score: 0.056
-
CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With Gastrointestinal Malignancies. J Cachexia Sarcopenia Muscle. 2025 Feb; 16(1):e13664.
Score: 0.052
-
A novel body composition risk score (B-Score) and overall survival among patients with nonmetastatic breast cancer. Clin Nutr. 2024 Apr; 43(4):981-987.
Score: 0.049
-
Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care. 2013 Dec; 36(12):3930-7.
Score: 0.047
-
Adipose tissue radiodensity and mortality among patients with nonmetastatic breast cancer. Clin Nutr. 2022 12; 41(12):2607-2613.
Score: 0.044
-
Low-energy reporting in women at risk for breast cancer recurrence. Women's Healthy Eating and Living Group. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1091-7.
Score: 0.038
-
Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
Score: 0.038
-
The Association of Abdominal Adiposity With Mortality in Patients With Stage I-III Colorectal Cancer. J Natl Cancer Inst. 2020 04 01; 112(4):377-383.
Score: 0.037
-
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev. 2019 12; 28(12):2062-2069.
Score: 0.036
-
Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer. 2017 Apr 01; 123(7):1228-1237.
Score: 0.030
-
Visceral adiposity and cancer survival: a review of imaging studies. Eur J Cancer Care (Engl). 2018 Mar; 27(2):e12611.
Score: 0.029
-
Post-diagnosis social networks, and lifestyle and treatment factors in the After Breast Cancer Pooling Project. Psychooncology. 2017 04; 26(4):544-552.
Score: 0.028
-
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis. 2016 Jan; 37(1):87-95.
Score: 0.027
-
Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015 Aug; 1(5):611-21.
Score: 0.027
-
Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project. J Natl Cancer Inst. 2014 Jan; 106(1):djt359.
Score: 0.024
-
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013 Dec; 24(12):2059-75.
Score: 0.024
-
The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control. 2013 Oct; 24(10):1821-36.
Score: 0.023
-
Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2013 Jun; 139(2):529-37.
Score: 0.023
-
Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
Score: 0.023
-
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 2013 Apr; 144(4):799-807.e24.
Score: 0.022
-
The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristics. Cancer Causes Control. 2011 Sep; 22(9):1319-31.
Score: 0.020
-
Marine fatty acid intake is associated with breast cancer prognosis. J Nutr. 2011 Feb; 141(2):201-6.
Score: 0.020
-
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011 Jun 01; 128(11):2726-34.
Score: 0.019
-
Alcohol consumption and rectal tumor mutations and epigenetic changes. Dis Colon Rectum. 2010 Aug; 53(8):1182-9.
Score: 0.019
-
Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat. 2011 Jan; 125(2):519-27.
Score: 0.019
-
Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010 Feb 20; 28(6):1005-10.
Score: 0.018
-
Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. 2010 Aug; 122(3):859-65.
Score: 0.018
-
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer. 2009 Dec 01; 125(11):2704-10.
Score: 0.018
-
Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):3079-85.
Score: 0.018
-
Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009 Nov; 20(9):1763-8.
Score: 0.018
-
Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. Am J Epidemiol. 2009 Jun 15; 169(12):1463-70.
Score: 0.017
-
The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
Score: 0.016
-
Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA. 2007 Jul 18; 298(3):289-98.
Score: 0.015
-
Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20; 23(27):6631-8.
Score: 0.014
-
Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control. 1999 Oct; 10(5):467-73.
Score: 0.009